Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIAL
Douglas Yee(University of Minnesota Medical Center), Si Fan(Nankai University), LJ van't Veer(University of Minnesota), Jacob Ritter(University of Minnesota), B Chen(University of Minnesota), Bhaskar Kallakury(Georgetown University), Andres Forero‐Torres(Kirklin Clinic), Farnaz Hasteh(University of California San Diego), Michael D. Feldman(University of Pennsylvania), Adnan Mansoor(University of Minnesota), Husain Sattar(University of Chicago), Martin Klein(Retina Foundation of the Southwest), Brian Datnow(University of California, San Diego), Steven Thornton(Queen Mary University of London), Shuko Harada(University of Alabama at Birmingham), Ann Tipps(University of Minnesota), Ronald Tickman(University of Minnesota), Tolgay I. Ocal(University of Minnesota), Sharon B. Sams(University of Colorado Denver), Ossama Tawfik(University Medical Center), Christina Yau(Hospital Authority), Shi Wei(University of Alabama at Birmingham), KS Albain(University of Minnesota), A. DeMichele(Hospital of the University of Pennsylvania), Claudine Isaacs(Georgetown University), Megan L. Troxell(Stanford University), Jane Perlmutter(Gemini Computers (United States)), Ronald Balassanian, Jay Zeck(Georgetown University), Lauren LeBeau(University of Arizona), Yung‐Yi Chen(University of Birmingham), J. Wisell(University of Minnesota), Nancy Klipfel(University of Minnesota), Hongtao Zhang(Chinese Academy of Sciences), Gregor Krings(Cleveland Clinic), MD Stamatakos(University of Minnesota), Tuyethoa N. Vinh(Inova Health System), Gary L. Keeney(Mayo Clinic in Arizona), K M Amin(University of Minnesota), HS Rugo(Texas Oncology), NM Hylton(University of Minnesota), Jeffery Mueller(University of Minnesota), Noel Weidner(University of Minnesota), F. Symmans(University of Minnesota), Çağatay Erşahin(University of Minnesota), K Gwin(University of Minnesota), R Gamez(University of Minnesota), Michelle Melisko(University of California, San Francisco), Xiuzhen Duan(Loyola University Chicago), Gabrielle M. Baker(Beth Israel Deaconess Medical Center)
Cited by 16
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k